● Nā maʻi hanu
-
ʻO ka maʻi influenza A H3N2 Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka maʻi influenza A H3N2 nucleic acid i nā laʻana swab nasopharyngeal kanaka.
-
ʻO ka maʻi Influenza maloʻo-hau/Maʻi Influenza B waikawa Nucleic
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka maʻi influenza A (IFV A) a me ka maʻi influenza B (IFV B) RNA i loko o nā hāpana swab nasopharyngeal kanaka.
-
ʻEono mau pathogens hanu i hoʻomaloʻo ʻia me ka hau Nucleic Acid
Hoʻohana ʻia kēia huahana no ka ʻike ʻana i ka qualitative in vitro o ka respiratory syncytial virus (RSV), adenovirus (Adv), human metapneumovirus (hMPV), rhinovirus (Rhv), parainfluenza virus type I/II/III (PIVI/II/III) a me Mycoplasma pneumoniae (MP) nucleic acids i loko o nā laʻana swab nasopharyngeal kanaka.
-
ʻEwalu ʻAno o nā Virus Hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi influenza A (IFV A), ka maʻi influenza B (IFVB), ka maʻi respiratory syncytial (RSV), adenovirus (Adv), human metapneumovirus (hMPV), rhinovirus (Rhv), Parainfluenza virus (PIV) a me Mycoplasma pneumoniae (MP) nucleic acids i loko o nā laʻana swab oropharyngeal kanaka a me nā laʻana swab nasopharyngeal.
-
ʻEiwa ʻAno o nā Virus Hanu
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka maʻi maʻi influenza A (IFV A), ka maʻi influenza B (IFVB), ka coronavirus hou (SARS-CoV-2), ka maʻi hanu syncytial (RSV), adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (RhV) a me ka maʻi virus parainfluenza (PIV) a me ka maʻi maʻi maʻi I/II/III. ʻakika nucleic i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.
-
Ka maʻi Influenza A / Ka maʻi Influenza B
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o ka maʻi influenza A a me ka maʻi influenza B RNA i nā hāpana swab oropharyngeal kanaka.
-
ʻEono mau mea hoʻomaʻi hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi respiratory syncytial (RSV), adenovirus (Adv), human metapneumovirus (hMPV), rhinovirus (Rhv), parainfluenza virus type I/II/III (PIVI/II/III), a me Mycoplasma pneumoniae (MP) nucleic acids i loko o nā hāpana swab oropharyngeal kanaka.
-
11 ʻAno o ka maʻi hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i nā maʻi hanu maʻamau i loko o ka sputum kanaka ma ke ʻano in vitro, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonas maltophilia (Smet), Bordetella pertussis (BP), Bacillus parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi i hoʻopaʻa ʻia ma ka haukapila a i ʻole nā maʻi koʻikoʻi me nā maʻi bacteria i manaʻo ʻia o ka ʻōpū hanu.Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i nā maʻi hanu maʻamau i loko o ka sputum kanaka ma ke ʻano in vitro, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonas maltophilia (Smet), Bordetella pertussis (BP), Bacillus parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi i hoʻopaʻa ʻia ma ka haukapila a i ʻole nā maʻi koʻikoʻi me nā maʻi bacteria i manaʻo ʻia o ka ʻōpū hanu.
-
14 ʻAno o nā pathogens hanu i hui pū ʻia
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2), ka maʻi Influenza A (IFV A), ka maʻi Influenza B (IFV B), ka maʻi maʻi hanu hanu (RSV), Adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ʻano maʻi virus Parainfluenza/IV/IV (PIIV) kanaka. (HBoV), Enterovirus (EV), Coronavirus (CoV), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), a me Streptococcus pneumoniae (SP) nucleic acids i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.
-
Ua hui pū ʻia nā pathogens hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o nā pathogens hanu i loko o ka nucleic acid i unuhi ʻia mai nā hāpana swab oropharyngeal kanaka.
Hoʻohana ʻia kēia kumu hoʻohālike no ka ʻike qualitative o 2019-nCoV, ka maʻi influenza A, ka maʻi influenza B a me nā nucleic acids o ka respiratory syncytial virus i loko o nā hāpana swab oropharyngeal kanaka.
-
Ua hui pū ʻia nā pathogens hanu
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi influenza A, ka maʻi influenza B, ka maʻi respiratory syncytial, adenovirus, human rhinovirus a me ka mycoplasma pneumoniae nucleic acids i loko o nā swab nasopharyngeal kanaka a me nā laʻana swab oropharyngeal. Hiki ke hoʻohana ʻia nā hopena hoʻāʻo no ke kōkua ʻana i ka ʻike ʻana i nā maʻi pathogen hanu, a hāʻawi i ke kumu diagnostic molecular kōkua no ka ʻike ʻana a me ka mālama ʻana i nā maʻi pathogen hanu.
-
SARS-CoV-2/maʻi palū A/maʻi palū B
He kūpono kēia pahu no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi influenza A a me ka maʻi influenza B nucleic acid o nā laʻana swab nasopharyngeal a me nā laʻana swab oropharyngeal o ka poʻe i manaʻo ʻia he maʻi SARS-CoV-2, influenza A a me ka maʻi influenza B. Hiki ke hoʻohana ʻia i nā hihia pneumonia i manaʻo ʻia a me nā hihia cluster i manaʻo ʻia a no ka ʻike ʻana a me ka ʻike ʻana i ka SARS-CoV-2, influenza A a me ka maʻi influenza B nucleic acid i nā laʻana swab nasopharyngeal a me nā laʻana swab oropharyngeal o ka maʻi Coronavirus hou i nā kūlana ʻē aʻe.
